Young rats injected with a synthetic cannabinoid have more of the brain’s motivating dopaminergic signaling and fewer numbers of inhibitory neurons than controls.
The neuronal coverings that mediate synaptic changes are involved in everything from memory to psychiatric disorders, affecting autism, Alzheimer’s, and addiction.